Kaplan Johanne
Chief Development Officer
Kaplan Johanne has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Kaplan Johanne is listed as Chief Development Officer at ProMIS Neurosciences Inc. Inside the rolling window, Kaplan Johanne reported 2 open-market purchases totaling $55K in PMN and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,280 PMN shares on Aug 5, 2026, worth $30K.
Companies traded
Other insiders at PMN
Insider Buying
$55K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kaplan Johanne made?
Kaplan Johanne has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Kaplan Johanne trade?
Kaplan Johanne has filed SEC Form 4 disclosures for 1 company, including PMN.
When was Kaplan Johanne's most recent SEC Form 4 filing?
Kaplan Johanne's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Kaplan Johanne's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kaplan Johanne is listed as Chief Development Officer.
What is Kaplan Johanne's total buy and sell value in the current window?
Inside the rolling retention window, Kaplan Johanne bought $55K and sold $0 based on SEC Form 4 filings.
What was Kaplan Johanne's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,280 PMN shares on 2026-08-05, worth $30K, per SEC Form 4 filings.